5 Results for "

Lats-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Lats-IN-1" in MCE Product Catalog:

33
33 Publications Verification
Cat. No.: HY-138489
CAS No.: 1424635-83-5
Purity:  99.22%
Synonyms: Lats-IN-1
Research Areas:  

Others

TRULI (Lats-IN-1) is a potent and ATP-competitive inhibitor of Lats1 and Lats2 kinases. TRULI promotes Yap-dependent proliferation in postmitotic mammalian tissues [1].
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-W011391
CAS No.: 67953-08-6
Target:  

Apoptosis ASCT

Research Areas:  

Cancer

GPNA hydrochloride is a well known substrate of the enzyme γ-glutamyltransferase (GGT). GPNA hydrochloride is a specific glutamine (Gln) transporter ASCT2 inhibitor. GPNA hydrochloride also inhibit Na +-dependent carriers, such as SNAT family (SNAT1/2/4/5), and the Na +-independent leucine transporters LAT1/2. GPNA reversibly induces apoptosis in A549 cells [1].
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-139330
CAS No.: 896657-58-2
Purity:  99.56%
Target:  

Apoptosis

Research Areas:  

Cancer

MGH-CP1 is a potent and orally active TEAD2 and TEAD4 auto-palmitoylation inhibitor with IC50s of 710 nM and 672 nM, respectively. MGH-CP1 can decrease the palmitoylation levels of endogenous or ectopically expressed TEAD proteins in cells. MGH-CP1 can suppress Myc expression, inhibit epithelial over-proliferation, and induce apoptosis when together with Lats1/2 deletion [1].
loading...
    loading...
Cat. No.: HY-187678
CAS No.: 3024011-79-5
NCGC-023 is a LATS1/2 inhibitor. NCGC-023 selectively inhibits LATS1/2, an upstream regulator of Yap in the Hippo signaling pathway, increases the expression of active Yap protein, activates Yap-dependent signaling pathways, triggers non-Yap-dependent metallothionein-mediated heavy metal responses, and upregulates IL-33-related regenerative responses. NCGC-023 can be used in studies related to gastrointestinal acute radiation syndrome (GI-ARS) [1] .
loading...
    loading...
Cat. No.: HY-183513
CAS No.: 2941355-27-5
Target:  

FAP

Research Areas:  

Cancer

L-Ala-BPA is a boron delivery agent. L-Ala-BPA is transported into tumor cells via PEPT1/2 and LAT-1 (SLC7A5) pathways and is rapidly cleaved systemically by endogenous proteases including FAP to yield L-BPA (HY-W087830). L-Ala-BPA shows antitumor activity and can be used for the research of Boron Neutron Capture Therapy (BNCT) [1].
loading...
    loading...